Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00775190 · ClinicalTrials.gov registry record · NA

Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives

A NA study, sponsored by Corewell Health East.

Terminated
Registry status
NA
Development phase
12
Enrollment target

NCT00775190 is a NA study that was terminated before completion, run by Corewell Health East. The registered enrollment target is 12 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00775190, a NA study, was terminated before completion, sponsored by Corewell Health East.

TERMINATED
Registry status
NA
Development phase
12 participants
Enrollment target

Study Summary

This is a randomized control trial of Ortho tricyclen versus Trinessa (generic equivalent) to determine if they have similar effects. Women will be randomized to receive either Ortho tricyclen or Trinessa oral contraceptives and will be asked to keep a daily dairy of any symptoms or bleeding experienced. Once a month, participants will be asked to complete a survey. The objective is to compare generic oral contraceptives (OCPs) and brand name OCPs with respect to side effect profiles including bleeding patterns, mood changes, nausea and vomiting, frequency of menstrual cramps, breast tenderness, elevation in blood pressure, stroke, blood clots and patient compliance.

Interventions

  • DRUG ortho tricyclen
  • DRUG Trinessa

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2008-10
Est. Completion 2013-11
Phase NA

Sponsor

Corewell Health East

106 total trials

What the Registry Record Tells You About NCT00775190

The ClinicalTrials.gov registry entry for NCT00775190 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which ortho tricyclen is the first listed.

NCT00775190 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00775190 about?

NCT00775190 is a clinical study titled "Side Effect Profiles of Brand Name Versus Generic Oral Contraceptives". This is a randomized control trial of Ortho tricyclen versus Trinessa (generic equivalent) to determine if they have similar effects. Women will be randomized to receive either Ortho tricyclen or Trinessa oral contraceptives and will be asked to keep a daily dairy of any symptoms or bleeding experie...

What is the current status of trial NCT00775190?

This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2008-10. Estimated completion is 2013-11.

What interventions are being tested in trial NCT00775190?

The interventions under investigation include: ortho tricyclen (DRUG), Trinessa (DRUG).

Who is sponsoring clinical trial NCT00775190?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.